Zyversa Therapeutics, Inc.

ZVSA

Financials

10-QQ1 ended 03/31/2605/13/26 10-KFY 202503/31/26 10-QQ3 ended 09/30/2511/19/25 10-QQ2 ended 06/30/2508/13/25 10-QQ1 ended 03/31/2505/12/25

Disclosures

8-KCurrent report07/16/26 8-KCurrent report07/10/26 8-KCurrent report03/05/26 8-KCurrent report12/03/25 8-KCurrent report11/19/25

Prospectuses and Registrations

S-1/ARegistration statement (amended)08/01/25 S-1/ARegistration statement (amended)07/18/25 S-1Registration statement (IPO)07/02/25 S-3Shelf registration04/04/25 S-8Registration of securities for employees01/24/25

Proxies

DEF 14ADefinitive proxy04/17/25 DEFA14AAdditional proxy materials04/17/25 PRE 14APreliminary proxy04/07/25 DEF 14ADefinitive proxy01/17/25 PRE 14APreliminary proxy12/20/24

Ownership

SC 13G/ABeneficial ownership (amended)08/14/25 Form 4Insider transaction07/16/25 Form 4Insider transaction07/15/25 Form 4Insider transaction07/15/25 Form 4Insider transaction07/15/25

Other

NT 10-QLate filing notification (10-Q)11/14/25 25-NSERemoval from listing10/06/25 EFFECTRequest for effectiveness08/06/25 CORRESPCorrespondence with the SEC08/05/25 CORRESPCorrespondence with the SEC08/01/25